Navigation Links
Over 60 Firms Confirmed to Attend CBI's Third Annual Bio/Pharmaceutical Collaboration and Transaction Accounting Conference in September

BOSTON, Aug. 27 /PRNewswire/ -- The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce their full agenda for the 3rd Annual Bio/Pharmaceutical Collaboration and Transaction Accounting. Over 60 firms are already confirmed to gather in Philadelphia on September 22nd for this one-day seminar to hear expert insights and discuss industry case examples for accounting for collaborations and transactions. Perspectives on FASB, IFRS and US GAAP, plus updates on the impact of EITF 07-1, EITF 99-19, EITF 00-21, EITF 07-3 and EITF 08-A will be presented.

The FASB and SEC are considering refinements to the collaboration accounting model. This, coupled with the trend of IFRS convergence, make it critical that life science companies master the financial accounting and reporting of deal-making activities. Amidst changing regulations, top executives from companies such as Goldman Sachs, FASB, GlaxoSmithKline, Infinity Pharmaceuticals and Johnson & Johnson will examine:

  • Recent Mergers and Acquisitions Impacting the Pharmaceutical Sector
  • Examples of Exotic Financings in Life Sciences
  • Trends in Deal Values and Economic Factors in Assessing and Valuing Innovation
  • Milestones and Revenue Arrangements with Multiple Deliverables
  • EITF Updates on Revenue Recognition and Capitalization of Milestone Payments
  • Considerations from a JFC Perspective for Joint Steering Committees (JSCs) and Other Joint Collaboration Meetings
  • FASB Accounting Guidelines for Collaborative Arrangements and Revenue Recognition

If you would like to view the full agenda, please visit this page. A "best-in-class" reputation, CPE credits and professional networking make this an extremely worthwhile event. For more information on this event, please visit If you would like to apply for a press pass, please contact Erica Kirwan of CBI at 339.298.2263.

About CBI:

A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy- and decision-makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit

This release was issued through eReleases(TM). For more information, visit

SOURCE Center for Business Intelligence
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ImmuneRegen BioSciences Confirms Homsperas Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration
2. Independent Study Confirms Superior Properties of ZPC(TM) Enhanced Calcium Composite Bone Grafts
3. Independent U.S. Study Confirms Veritides Ceeker(TM) Handheld Device Detects Anthrax With Outstanding Accuracy and Reliability
4. Dow AgroSciences Confirms Efficacy of Zinc Finger Nucleases for Precise Genome Modification in Maize
5. Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010
6. NIH News Confirms Trend in Stem Cell Storage Facilities, says CEO of San Diego-based Bio-Matrix Scientific Group
7. GDFII/L&P Confirms Target Date Extension Of U.S. ITC Sucralose Ruling
8. Mylan Confirms Four First-to-File Challenges
9. Gentag, Inc. Engages US and UK Firms to Explore Strategic Options
10. Three Firms, Two Training Programs Garner Greater Baltimore Committees 2009 Bioscience Awards
11. Amylin Pharmaceuticals Confirms Receipt of Director Nomination Notices
Post Your Comments:
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... will be hosting a Webinar titled, “Pathology is going digital. Is your lab ... digital pathology adoption best practices and how Proscia improves lab economics and realizes ...
(Date:10/11/2017)... ... 11, 2017 , ... Disappearing forests and increased emissions are the main causes ... each year. Especially those living in larger cities are affected by air pollution related ... the most pollution-affected countries globally - decided to take action. , “I knew I ...
(Date:10/10/2017)... ... 10, 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, ... The bold new look is part of a transformation to increase awareness, appeal ... growth period. , It will also expand its service offering from its signature gourmet ...
Breaking Biology Technology:
(Date:4/11/2017)... April 11, 2017 Crossmatch®, a globally-recognized ... solutions, today announced that it has been awarded ... Projects Activity (IARPA) to develop next-generation Presentation Attack ... "Innovation has been a driving force within ... will allow us to innovate and develop new ...
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):